(Q40988623)

English

Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors.

scientific article published on December 1995

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

review article

1 reference

stated in

Europe PubMed Central

title

Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

author name string

Palacios JM

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

Beleta J

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

Segarra V

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

publication date

1 December 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

volume

50

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

page(s)

819-827

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

Identifiers

PubMed publication ID

8634072

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8634072

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8634072%20AND%20SRC:MED&resulttype=core&format=json

(Q40988623)

Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)